Ozagrel

CAS No. 82571-53-7

Ozagrel( OKY-046 )

Catalog No. M16065 CAS No. 82571-53-7

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 Get Quote
10MG 47 Get Quote
25MG 77 Get Quote
50MG 109 Get Quote
100MG 164 Get Quote
200MG 212 Get Quote
500MG 356 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ozagrel
  • Note
    Research use only, not for human use.
  • Brief Description
    Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
  • Description
    Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    OKY-046
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thromboxane A2 synthetase
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    82571-53-7
  • Formula Weight
    228.25
  • Molecular Formula
    C13H12N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 46 mg/mL (201.53 mM)
  • SMILES
    C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ishitsuka Y, et al. J Pharmacol Sci, 2009, 111(2), 211-215.
molnova catalog
related products
  • Dabigatran etexilate

    A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM.

  • Efegatran sulfate

    Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.

  • Etamsylate

    Ethamsylate is a haemostatic drug, which inhibits biosynthesis and action of prostaglandins, and increases capillary endothelial resistance as and platelet adhesion.